Comgest Global Investors’s Thermo Fisher Scientific TMO Stock Holding History

Comgest Global Investors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,515	Closed	-$614K	–	66
2025 Q2	$614K	Buy	1,515 +59	+4%	+$24.7K	0.01%	63
2025 Q1	$725K	Hold	1,456	–	–	0.01%	61
2024 Q4	$757K	Hold	1,456	–	–	0.01%	59
2024 Q3	$901K	Buy	1,456 +373	+34%	+$221K	0.01%	58
2024 Q2	$599K	Hold	1,083	–	–	0.01%	64
2024 Q1	$629K	Sell	1,083 -137	-11%	-$76.9K	0.01%	63
2023 Q4	$648K	Hold	1,220	–	–	0.01%	62
2023 Q3	$618K	Buy	1,220 +620	+103%	+$330K	0.01%	64
2023 Q2	$313K	Buy	600 +32	+6%	+$17.3K	0.01%	66
2023 Q1	$327K	Sell	568 -4,134	-88%	-$2.33M	0.01%	66
2022 Q4	$2.59M	Buy	4,702 +358	+8%	+$190K	0.06%	49
2022 Q3	$2.2M	Buy	+4,344	New	+$2.43M	0.05%	53

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Comgest Global Investors's TMO Position: Q3 2025 in Review

Comgest Global Investors sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 1,515 shares — an estimated $614K sold.

Comgest Global Investors first reported a position in TMO in Q3 2022 and held it in 12 quarters. The position peaked at $2.59M in Q4 2022. 2,508 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Comgest Global Investors reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Comgest Global Investors sold 1,515 Thermo Fisher Scientific shares in Q3 2025, an estimated $614K.
Comgest Global Investors first reported a position in Thermo Fisher Scientific in Q3 2022 and held it in 12 quarters.
Comgest Global Investors's Thermo Fisher Scientific position peaked at $2.59M in Q4 2022.
2,508 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Comgest Global Investors's 13F filing for Q3 2025, filed 7 Nov 2025.